Cargando…

Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.

Detalles Bibliográficos
Autores principales:	Aitchison, R. G., Reilly, I. A., Morgan, A. G., Russell, N. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971600/ https://www.ncbi.nlm.nih.gov/pubmed/2337514

Ejemplares similares

Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients.
por: Forgeson, G. V., et al.
Publicado: (1988)

Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton
por: Yin, Lei, et al.
Publicado: (2017)

Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience
por: Berruti, A, et al.
Publicado: (1999)

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma
por: Chim, C. S., et al.
Publicado: (2010)

Colon perforation in multiple myeloma patients – A complication of high‐dose steroid treatment
por: Vaxman, Iuliana, et al.
Publicado: (2020)

Pulsed Vincristine Therapy in Steroid-Resistant Nephrotic Syndrome
por: Thalgahagoda, Shenal, et al.
Publicado: (2017)

Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.
por: Twentyman, P. R., et al.
Publicado: (1987)

Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience
por: Hagmann, Raphael, et al.
Publicado: (2015)

Successful management of refractory pleural effusion due to systemic immunoglobulin light chain amyloidosis by vincristine adriamycin dexamethasone chemotherapy: a case report
por: Araoka, Toshikazu, et al.
Publicado: (2010)

COMPLICATIONS OF HIGH-DOSE STEROIDS IN COVID-19
por: KAUR, TANISHA, et al.
Publicado: (2021)

Complete remission of lambda light chain myeloma presenting with acute renal failure following treatment with bortezomib and steroids
por: Pavan, M., et al.
Publicado: (2010)

Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012)

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin
por: Tomida, Akihiro, et al.
Publicado: (1995)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Biclonal myeloma in renal failure
por: NIKOLOVA-VLAHOVA, MILENA K., et al.
Publicado: (2020)

Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer
por: Jung, Sang Ok, et al.
Publicado: (2015)

Evaluate the Response Rate of Acute Lymphocytic Leukemia Patients to Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone Regimen and Remission Rate to Stay Until the End of the Arbitrary Treatment
por: Mehrzad, Valiollah, et al.
Publicado: (2018)

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.
por: Carmo-Pereira, J., et al.
Publicado: (1987)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding
por: Alwhaibi, Abdulrahman M., et al.
Publicado: (2023)

Platelet number and function in response to a single intravenous dose of vincristine
por: Allen, Erin C., et al.
Publicado: (2021)

Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy
por: Kim, Da Rae, et al.
Publicado: (2017)

Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
por: Kim, Hyung Sook, et al.
Publicado: (2019)

Diffuse Intrasinusoidal Hepatic Metastasis from Breast Cancer Presenting as Liver Failure: Effective and Rapid Treatment with Weekly Low-Dose Adriamycin
por: Afiat, Thanh-Phuong N., et al.
Publicado: (2020)

Vincristine dosing, drug exposure and therapeutic drug monitoring in neonate and infant cancer patients
por: Barnett, Shelby, et al.
Publicado: (2022)

Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments.
por: Braunschweiger, P. G., et al.
Publicado: (1982)

Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
por: Diouf, Barthelemy, et al.
Publicado: (2021)

Multiple myeloma presented as acute renal failure
por: Momeni, Ali, et al.
Publicado: (2013)

Vincristine-Induced Acrocyanosis and Erythema Pernio
por: Middleton, Hayden T., et al.
Publicado: (2023)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer
por: Ren, Boxue, et al.
Publicado: (2019)

Vincristine-Induced Cranial Neuropathy
por: TALEBIAN, Ahmad, et al.
Publicado: (2014)

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy
por: Hatzl, Stefan, et al.
Publicado: (2021)

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Vincristine-Induced Peripheral Neuropathy in Children With Malignancy and the Effect of Missed Doses on Treatment Success
por: Eker, Nurşah, et al.
Publicado: (2023)

A Comparison of the Long-Term Effects of Lanthanum Carbonate and Calcium Carbonate on the Course of Chronic Renal Failure in Rats with Adriamycin-Induced Nephropathy
por: Takashima, Tsuyoshi, et al.
Publicado: (2014)

Immune-mediated vincristine-induced neuropathy: Unlocking therapies
por: Savelieff, Masha G., et al.
Publicado: (2021)

Inhibition of Cyclooxygenase-2 Reduces Hypothalamic Excitation in Rats with Adriamycin-Induced Heart Failure
por: Zheng, Min, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n4664kubm8sjmq6vb4k2b2t24n